Inventor · disambiguated record
Arnon Rosenthal
Also filed as: ROSENTHAL ARNON
120 granted patents·77 pending applications·1,269 citations·filing 1990–2025
99Inventor score
Files withALECTOR LLC88GENENTECH INC30RINAT NEUROSCIENCE CORP18ANNEXON INC17TEVA PHARMACEUTICALS INT GMBH10
Top patents by PatentIndex Score
197 records- 0198US8734802B1Methods of treating vasomotor symptoms using antibodiesLABRYS BIOLOG INC·Filed 2013·Granted May 27, 2014·54 cites·20 claims
- 0298US8597649B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2013·Granted Dec 3, 2013·51 cites·9 claims
- 0398US7655232B2Anti-NGF antibodies and methods using samePFIZER·Filed 2007·Granted Feb 2, 2010·60 cites·12 claims
- 0497US9884907B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0597US9884908B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0697US9346881B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 24, 2016·16 cites·19 claims
- 0797US9340614B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 17, 2016·16 cites·20 claims
- 0897US9266951B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted Feb 23, 2016·23 cites·19 claims
- 0997US9115194B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2014·Granted Aug 25, 2015·26 cites·20 claims
- 1097US8007794B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Aug 30, 2011·51 cites·9 claims
- 1197US7449616B2Anti-NGF antibodies and methods using samePFIZER·Filed 2003·Granted Nov 11, 2008·93 cites·12 claims
- 1296US11186645B2Isolated nucleic acids encoding anti-sortilin antibodiesALECTOR LLC·Filed 2020·Granted Nov 30, 2021·4 cites·48 claims
- 1396US10927167B2Anti-complement factor C1Q antibodies and uses thereofANNEXON INC·Filed 2020·Granted Feb 23, 2021·4 cites·19 claims
- 1496US10676525B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 9, 2020·13 cites·60 claims
- 1596US9890210B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1696US9890211B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1796US9365648B1Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2016·Granted Jun 14, 2016·16 cites·29 claims
- 1896US9328168B2Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2015·Granted May 3, 2016·16 cites·30 claims
- 1996US8586045B2Methods of using anti-CGRP antagonist antibodiesZELLER JOERG·Filed 2011·Granted Nov 19, 2013·61 cites·31 claims
- 2096US7569364B2Anti-NGF antibodies and methods using samePFIZER·Filed 2005·Granted Aug 4, 2009·60 cites·16 claims
- 2194US10087255B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 2, 2018·12 cites·17 claims
- 2294US8088384B2Anti-NGF antibodies and methods using samePONS JAUME·Filed 2009·Granted Jan 3, 2012·22 cites·11 claims
- 2394US7927594B2Antibodies directed against amyloid-beta peptideRINAT NEUROSCIENCE CORP·Filed 2005·Granted Apr 19, 2011·24 cites·21 claims
- 2494US7763250B2Antibodies directed against amyloid-beta peptide and nucleic acids encoding sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Jul 27, 2010·23 cites·29 claims
- 2593US11208488B2Methods of increasing progranulin levels using anti-Sortilin antibodiesALECTOR LLC·Filed 2018·Granted Dec 28, 2021·4 cites·44 claims
- 2693US10849992B1Methods of screening for sortilin binding antagonistsALECTOR LLC·Filed 2016·Granted Dec 1, 2020·6 cites·8 claims
- 2793US10711062B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jul 14, 2020·7 cites·77 claims
- 2893US10329343B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 25, 2019·5 cites·24 claims
- 2993US7785588B2Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factorsGENENTECH INC·Filed 2006·Granted Aug 31, 2010·14 cites·7 claims
- 3092US11649279B2Anti-complement factor C1Q antibodies and uses thereofANNEXON INC·Filed 2021·Granted May 16, 2023·2 cites·21 claims
- 3192US10723788B2Anti-complement factor C1q Fab fragments and uses thereofANNEXON INC·Filed 2016·Granted Jul 28, 2020·6 cites·20 claims
- 3292US10590190B2Anti-complement factor C1q antibodies and uses thereofANNEXON INC·Filed 2019·Granted Mar 17, 2020·8 cites·22 claims
- 3392US9708394B2Anti-complement factor C1q antibodies and uses thereofANNEXON INC·Filed 2016·Granted Jul 18, 2017·10 cites·28 claims
- 3491US11084875B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Aug 10, 2021·4 cites·26 claims
- 3591US10428150B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Oct 1, 2019·6 cites·17 claims
- 3691US10316081B2Humanized anti-complement factor C1Q antibodiesANNEXON INC·Filed 2015·Granted Jun 11, 2019·10 cites·30 claims
- 3791US10227398B2Anti-complement factor C1q antibodies and uses thereofANNEXON INC·Filed 2017·Granted Mar 12, 2019·8 cites·30 claims
- 3891US8540990B2Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameROSENTHAL ARNON·Filed 2006·Granted Sep 24, 2013·20 cites·38 claims
- 3991US2025092144A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2024·Application pending·0 cites
- 4090US11999779B2Anti-complement factor C1q Fab fragments and uses thereofANNEXON INC·Filed 2020·Granted Jun 4, 2024·2 cites·19 claims
- 4190US11965023B2Anti-Siglec-5 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Apr 23, 2024·1 cites·32 claims
- 4290US11634489B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Apr 25, 2023·2 cites·32 claims
- 4390US11254743B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Feb 22, 2022·2 cites·20 claims
- 4490US10308718B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 4, 2019·6 cites·21 claims
- 4590US2024158481A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Application pending·0 cites
- 4689US11667699B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jun 6, 2023·3 cites·93 claims
- 4789US11339223B2Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2018·Granted May 24, 2022·2 cites·59 claims
- 4888US12258410B2Anti-SIRPα antibodies and methods of use thereofALECTOR LLC·Filed 2024·Granted Mar 25, 2025·0 cites·76 claims
- 4988US11396546B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Jul 26, 2022·2 cites·22 claims
- 5088US7691973B2GFRα3 polypeptidesGENENTECH INC·Filed 2006·Granted Apr 6, 2010·7 cites·11 claims
Showing the top 50 of 197 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Arnon Rosenthal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →